Abdul Abdirahman
Principal
F-Prime
Principal investing in early-stage B2B software, fintech, and vertical SaaS.
Bio
Professional summary
Olivia Carlson is a Senior Associate at F-Prime focused on healthcare technology and services investments. Before F-Prime, she was an investor at M33 Growth, where she assessed investment opportunities and supported growth-stage healthcare portfolio companies. She also worked in strategy consulting for EY-Parthenon's healthcare team and started her career as a certified nursing assistant.
Background
Career, education, and skills
Career history
- F-Prime CapitalSenior Associate
- M33 GrowthInvestor
- EY-ParthenonStrategy Consultant, Healthcare
- Home health and hospice companyCertified Nursing Assistant
Education
- Williams CollegeBA, Pre-Medical Studies and Psychology
Other partners at F-Prime
12 more profiles
Alex Pasteur
Partner
F-Prime
Alex Pasteur is a London-based Partner at F-Prime Capital focused on therapeutics and life sciences.
AP
Anastasiya Sybirna, PhD
Senior Associate
F-Prime
Senior Associate on F-Prime's London healthcare investment team.
Bala Varadhan
Principal
F-Prime
Principal focused on early-stage crypto, blockchain and Web3 investments.
Benjamin Gorman
Principal
F-Prime
Principal investing in early-stage enterprise software and AI.
Betsy Mulé
Principal
F-Prime
Principal investing in enterprise technology and robotics.
Brett Cook
Partner
F-Prime
F-Prime Partner investing in healthcare technology and services companies.
Brian Yordy
Principal
F-Prime
Principal investing in biopharmaceutical and medical technology companies.
Carl Bradford Byers 🚑
Partner
F-Prime
F-Prime Partner and former athenahealth founding CFO investing in healthcare IT and digital health.
Carl Byers
Partner
F-Prime
Carl Byers is a Partner at F-Prime Capital with significant operating experience in healthcare IT, including as a founding team member and CFO of athenahealth.
Chance Mathisen
Associate
F-Prime
Associate focused on early-stage enterprise software investments.
Chong Xu
Partner
F-Prime
F-Prime partner focused on biopharma, medtech, company formation, and China healthcare opportunities.